|
ISCU expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.179300E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.941600E-02 |
| Normal-vs-Stage2 |
2.817400E-01 |
| Normal-vs-Stage3 |
9.255600E-02 |
| Normal-vs-Stage4 |
2.614200E-01 |
| Stage1-vs-Stage2 |
9.049800E-01 |
| Stage1-vs-Stage3 |
6.060400E-01 |
| Stage1-vs-Stage4 |
6.942000E-01 |
| Stage2-vs-Stage3 |
5.820800E-01 |
| Stage2-vs-Stage4 |
5.978200E-01 |
| Stage3-vs-Stage4 |
9.495800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.616300E-02 |
| Normal-vs-AfricanAmerican |
1.761550E-02 |
| Normal-vs-Asian |
5.024000E-01 |
| Caucasian-vs-AfricanAmerican |
6.596000E-01 |
| Caucasian-vs-Asian |
8.089800E-01 |
| AfricanAmerican-vs-Asian |
8.646600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.197900E-03 |
| Normal-vs-Female |
4.098400E-02 |
| Male-vs-Female |
7.913800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.240000E-02 |
| Normal-vs-Extreme_Weight |
1.319550E-02 |
| Normal-vs-Obese |
3.601600E-01 |
| Normal-vs-Extreme_Obese |
4.187000E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.668600E-01 |
| Normal_Weight-vs-Obese |
7.554200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.882000E-01 |
| Extreme_Weight-vs-Obese |
6.399800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.085800E-01 |
| Obese-vs-Extreme_Obese |
9.829400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.040000E-02 |
| Normal-vs-Age(41-60Yrs) |
7.902900E-03 |
| Normal-vs-Age(61-80Yrs) |
7.926100E-02 |
| Normal-vs-Age(81-100Yrs) |
9.147400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.578000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.041600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.267600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.539600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.267840E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.942400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.573000E-04 |
| Normal-VS-Type2 PRCC |
7.851400E-01 |
| Normal-VS-KIRP CIMP |
2.379800E-04 |
| Normal-VS-Unclassified PRCC |
4.391800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.762400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.757900E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.904600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.191310E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
4.421800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.755800E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.210000E-02 |
| Normal-vs-N1 |
3.282100E-03 |
| Normal-vs-N2 |
7.556400E-01 |
| N0-vs-N1 |
1.423450E-01 |
| N0-vs-N2 |
7.832800E-01 |
| N1-vs-N2 |
3.289200E-01 |
|
|
